Modest weight loss associated with the use of lorcaserin has been shown to improve cardiometabolic health in people who are overweight, obese or have a high cardiovascular risk. The findings with the serotonergic agonist are consistent with other evidence such as the DiRECT trial that weight loss can help with remission with type 2 diabetes. ...
Weight loss drug lorcaserin improves cardiometabolic health
By Mardi Chapman
16 Oct 2018